Cargando…

MAVEN: compound mechanism of action analysis and visualisation using transcriptomics and compound structure data in R/Shiny

BACKGROUND: Understanding the Mechanism of Action (MoA) of a compound is an often challenging but equally crucial aspect of drug discovery that can help improve both its efficacy and safety. Computational methods to aid MoA elucidation usually either aim to predict direct drug targets, or attempt to...

Descripción completa

Detalles Bibliográficos
Autores principales: Hosseini-Gerami, Layla, Hernansaiz Ballesteros, Rosa, Liu, Anika, Broughton, Howard, Collier, David Andrew, Bender, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502988/
https://www.ncbi.nlm.nih.gov/pubmed/37715141
http://dx.doi.org/10.1186/s12859-023-05416-8
_version_ 1785106426820034560
author Hosseini-Gerami, Layla
Hernansaiz Ballesteros, Rosa
Liu, Anika
Broughton, Howard
Collier, David Andrew
Bender, Andreas
author_facet Hosseini-Gerami, Layla
Hernansaiz Ballesteros, Rosa
Liu, Anika
Broughton, Howard
Collier, David Andrew
Bender, Andreas
author_sort Hosseini-Gerami, Layla
collection PubMed
description BACKGROUND: Understanding the Mechanism of Action (MoA) of a compound is an often challenging but equally crucial aspect of drug discovery that can help improve both its efficacy and safety. Computational methods to aid MoA elucidation usually either aim to predict direct drug targets, or attempt to understand modulated downstream pathways or signalling proteins. Such methods usually require extensive coding experience and results are often optimised for further computational processing, making them difficult for wet-lab scientists to perform, interpret and draw hypotheses from. RESULTS: To address this issue, we in this work present MAVEN (Mechanism of Action Visualisation and Enrichment), an R/Shiny app which allows for GUI-based prediction of drug targets based on chemical structure, combined with causal reasoning based on causal protein–protein interactions and transcriptomic perturbation signatures. The app computes a systems-level view of the mechanism of action of the input compound. This is visualised as a sub-network linking predicted or known targets to modulated transcription factors via inferred signalling proteins. The tool includes a selection of MSigDB gene set collections to perform pathway enrichment on the resulting network, and also allows for custom gene sets to be uploaded by the researcher. MAVEN is hence a user-friendly, flexible tool for researchers without extensive bioinformatics or cheminformatics knowledge to generate interpretable hypotheses of compound Mechanism of Action. CONCLUSIONS: MAVEN is available as a fully open-source tool at https://github.com/laylagerami/MAVEN with options to install in a Docker or Singularity container. Full documentation, including a tutorial on example data, is available at https://laylagerami.github.io/MAVEN.
format Online
Article
Text
id pubmed-10502988
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-105029882023-09-16 MAVEN: compound mechanism of action analysis and visualisation using transcriptomics and compound structure data in R/Shiny Hosseini-Gerami, Layla Hernansaiz Ballesteros, Rosa Liu, Anika Broughton, Howard Collier, David Andrew Bender, Andreas BMC Bioinformatics Software BACKGROUND: Understanding the Mechanism of Action (MoA) of a compound is an often challenging but equally crucial aspect of drug discovery that can help improve both its efficacy and safety. Computational methods to aid MoA elucidation usually either aim to predict direct drug targets, or attempt to understand modulated downstream pathways or signalling proteins. Such methods usually require extensive coding experience and results are often optimised for further computational processing, making them difficult for wet-lab scientists to perform, interpret and draw hypotheses from. RESULTS: To address this issue, we in this work present MAVEN (Mechanism of Action Visualisation and Enrichment), an R/Shiny app which allows for GUI-based prediction of drug targets based on chemical structure, combined with causal reasoning based on causal protein–protein interactions and transcriptomic perturbation signatures. The app computes a systems-level view of the mechanism of action of the input compound. This is visualised as a sub-network linking predicted or known targets to modulated transcription factors via inferred signalling proteins. The tool includes a selection of MSigDB gene set collections to perform pathway enrichment on the resulting network, and also allows for custom gene sets to be uploaded by the researcher. MAVEN is hence a user-friendly, flexible tool for researchers without extensive bioinformatics or cheminformatics knowledge to generate interpretable hypotheses of compound Mechanism of Action. CONCLUSIONS: MAVEN is available as a fully open-source tool at https://github.com/laylagerami/MAVEN with options to install in a Docker or Singularity container. Full documentation, including a tutorial on example data, is available at https://laylagerami.github.io/MAVEN. BioMed Central 2023-09-15 /pmc/articles/PMC10502988/ /pubmed/37715141 http://dx.doi.org/10.1186/s12859-023-05416-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Software
Hosseini-Gerami, Layla
Hernansaiz Ballesteros, Rosa
Liu, Anika
Broughton, Howard
Collier, David Andrew
Bender, Andreas
MAVEN: compound mechanism of action analysis and visualisation using transcriptomics and compound structure data in R/Shiny
title MAVEN: compound mechanism of action analysis and visualisation using transcriptomics and compound structure data in R/Shiny
title_full MAVEN: compound mechanism of action analysis and visualisation using transcriptomics and compound structure data in R/Shiny
title_fullStr MAVEN: compound mechanism of action analysis and visualisation using transcriptomics and compound structure data in R/Shiny
title_full_unstemmed MAVEN: compound mechanism of action analysis and visualisation using transcriptomics and compound structure data in R/Shiny
title_short MAVEN: compound mechanism of action analysis and visualisation using transcriptomics and compound structure data in R/Shiny
title_sort maven: compound mechanism of action analysis and visualisation using transcriptomics and compound structure data in r/shiny
topic Software
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502988/
https://www.ncbi.nlm.nih.gov/pubmed/37715141
http://dx.doi.org/10.1186/s12859-023-05416-8
work_keys_str_mv AT hosseinigeramilayla mavencompoundmechanismofactionanalysisandvisualisationusingtranscriptomicsandcompoundstructuredatainrshiny
AT hernansaizballesterosrosa mavencompoundmechanismofactionanalysisandvisualisationusingtranscriptomicsandcompoundstructuredatainrshiny
AT liuanika mavencompoundmechanismofactionanalysisandvisualisationusingtranscriptomicsandcompoundstructuredatainrshiny
AT broughtonhoward mavencompoundmechanismofactionanalysisandvisualisationusingtranscriptomicsandcompoundstructuredatainrshiny
AT collierdavidandrew mavencompoundmechanismofactionanalysisandvisualisationusingtranscriptomicsandcompoundstructuredatainrshiny
AT benderandreas mavencompoundmechanismofactionanalysisandvisualisationusingtranscriptomicsandcompoundstructuredatainrshiny